Image taken from Roche website http://www.roche.com/research_and_development/drawn_to_science/target_identification.htm

Rethinking Drug Discovery & Research Models in India

Drug discovery is a high risk, high return business. Despite the intrinsic risks, pharma companies continue to invest heavily in R&D to improve the quality of life of patients in needs of treatment. While capital is important in R&D outcomes, innovation-based organisations need to understand the best model to adopt to speed up the process in bringing discoveries to useful commercial …

5 minutes with Dr Subhadra Dravida, Founder and CEO of Transcell

Transcell Biologics is an innovative biotech company focuses in anti-cancer treatment, neurological ailments and autoimmune disorder. The innovative, stem cell based biotech company is based in Hyderabad, India. Ahead of this year’s BioPharma India 2016, we had the pleasure of grabbing a few minutes with its founder and CEO, Dr Subhadra Dravida.   What sparked the establishment of Transcell? We hope to translate stem cell …

The art of repositioning drugs: An interview with NovaLead Pharma’s Supreet Deshpande

Inventing a new drug requires huge financial commitment and it’s a lengthy process until it reaches patients in need. However, discovering a new application of an already clinically-approved drug saves you both time and allows you to fully utilise the power of your existing arsenal. Since the original drug application has a known function and toxicity, drug repurposing saves time and …

Top 54 most influential individuals in India’s biopharma industry

After months of research and rounds of surveys , we have finalised the list of top 54 most influential individuals in India’s biopharma industry. Congratulations to our industry leaders from Biocon, Biological E, Dr Reddy’s Laboratories, Sun Pharma, Serum Institute of India, Cadila Healthcare, Lupin and many more. Simply click here to get your free copy of this ebook. You may also want …

The voting system for India’s Top 50 biopharma leaders shut down tonight

We have gathered an encouraging number of votes from the community, thank you for your support. Here is the current voting result for the top 50 most influential leaders within India’s biopharma industry. Ranking Candidate Percentage of vote 1 Mrs. Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon 54.70% 2 Mahima Datla, Managing Director, Biological E 41.50% 2 Mr G. V. …

Who are the top 50 leaders in India’s Biopharma industry?

In an effort to publish reliable and useful content for the members of our online community, we gather feedback from the industry to list outtop 50 most influential individuals in the current bio-pharmaceutical industry in India. This ebook is a complimentary effort by our BioPharma India Convention team to thank the industry for their continuous support in the past 13 years. An encouraging amount …

3 Key Takeaways from BioPharma Asia Convention 2015

Just over a month ago, BioPharma Asia Convention celebrated its 8th success in Singapore. With a larger focus of areas including vaccines, novel biologics, generics and more, the event gathered the APAC region for a good 3 days of networking and learning. Kelvin of Lionbridge has shared an elaborate post on what he discovered by not just attending the event, …

Media Release : Winners of the 5th BioPharma Asia Industry Awards

10 organisations and individuals were recognised for their significant contributions on 24 March, at the 5th BioPharma Industry Awards Gala Dinner, held in conjunction with the 8th BioPharma Asia Convention 2015. The award winners are as follows. Outsourcing Category Best Contract Research Organisation — PRA Health Sciences Best Contract Manufacturing Organisation — Kemwell BioPharma, India Logistics Category Best Cold Chain …

Leaders of Asia — Interview with Anand Tharmaratnam, Senior Vice President & Head of Asia Markets, Quintiles East Asia

How is it like to overseeing the world’s largest CRO’s clinical development and market access businesses across 13 Asia-Pacific countries that account for half the world’s population – including Japan and China, the world’s second- and third-largest biopharmaceutical markets, respectively? It is definitely not a walk in the park for some others but it’s all in a day’s job for …